Loading interface...

Telsar LN-5 Tablet

Manufactured byTORRENT PHARMACEUTICALS LTD
ContainsCilnidipine (5 mg) + Telmisartan (40 mg)
Description
Telsar LN-5 Tablet is a combination of Cilnidipine and Telmisartan. It is used in the treatment of high blood pressure. This medicine relaxes the blood vessels and controls high blood pressure. Telsar LN-5 Tablet shows side effects like swelling in your ankles or feet, headache, tiredness, nausea, and stomach upset. These side effects usually subside with time. However, consult your doctor for further assistance if they persist or worsen. Avoid driving vehicles or operating heavy machines while taking this medication as it can cause dizziness. Avoid consuming grapefruit juice with this medicine as it can cause serious side effects. Telsar LN-5 Tablet can be taken with or without food. Do not chew, crush, or break the tablet. Swallow it as a whole with a glass of water. Take the medicine at the same time every day for ease of remembering. Do not discontinue the medicine without consulting your doctor as it may worsen the condition. You are advised to make some lifestyle changes such as indulging in physical activities and a low-salt diet intake. Telsar LN-5 Tablet is not recommended for use if you are allergic to it. Inform your doctor about all your ongoing medicines as they can interact with each other and cause serious side effects. Inform your doctor if you have pre-existing liver, or kidney problems or any other health conditions. Consult your doctor if you are pregnant or breastfeeding before taking this medicine. It is not recommended for children below 18 years of age as safety and efficacy have not been established.

Side effects

Major & minor side effects for Telsar LN-5 Tablet

  • Dizziness
  • Upset stomach
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Increased potassium levels

Uses of Telsar LN-5 Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Telsar LN-5 Tablet can be observed within three hours.
  • How long do the effects of this medicine last?
    Telsar LN-5 Tablet may remain effective in your body for 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment of this medicine due to the increased risk of dizziness, fainting, and a very low blood pressure. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Telsar LN-5 Tablet.
  • Can this medicine be taken during pregnancy?
    Telsar LN-5 Tablet is not recommended for use in pregnancy as it can harm your foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Telsar LN-5 Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breast milk. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking Telsar LN-5 Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, swelling and/or itching (especially in the face, lips, throat, etc.), dizziness, breathing difficulty, etc.

Aliskiren

Avoid taking Telsar LN-5 Tablet and Aliskiren (a medicine used for reducing high blood pressure) together as it may lead to kidney damage, low blood pressure, and hyperkalaemia (high potassium levels in your blood). It may also cause other side effects such as irregular heartbeat, muscle paralysis, heart attack, etc. This risk is particularly higher if you have diabetes or kidney problems or in the elderly.

Severe liver impairment

Telsar LN-5 Tablet is not recommended for use if you have severe liver problems. Impaired liver function may lead to the accumulation of this medicine in the body and increase the risk of side effects. It may also cause further liver damage.
Warnings for special population

Pregnancy

Telsar LN-5 Tablet is not recommended for use in pregnancy as it can harm your foetus. Consult your doctor if you are pregnant.

Breast-feeding

Telsar LN-5 Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breast milk. Consult your doctor if you are breastfeeding.
General warnings

Aortic Stenosis

Telsar LN-5 Tablet should be used with caution if you have aortic stenosis (narrowing of the aortic valve that regulates blood flow from the chamber of the heart to the body) due to the increased risk of hypotension (low blood pressure). Hence, regularly monitor your blood pressure during treatment with this medicine. Your doctor may adjust the dose of the medicine as per requirements.

Use in Children

Telsar LN-5 Tablet is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established.

Renal artery stenosis

Renal artery stenosis is the narrowing or blockage of blood vessels that carry blood to your kidneys. Telsar LN-5 Tablet should be used with caution if you have renal artery stenosis as it may cause uncontrolled high blood pressure, altered kidney function, water retention, and swelling of the body (majorly in the hands and feet). Your kidney function and clinical condition will be closely monitored by your doctor while you are on treatment with this medicine.

Drug Withdrawal

Avoid abrupt discontinuation of Telsar LN-5 Tablet as it may worsen conditions such as angina (chest pain). Your doctor may gradually reduce the dose based on your condition to avoid undesirable effects.

Hyperkalemia

Hyperkalaemia is an increase in potassium levels in your blood. Telsar LN-5 Tablet may lead to hyperkalaemia and cause side effects such as irregular heartbeats. Hence avoid potassium-rich foods (such as potatoes, bananas, etc.) and other medicines or supplements that may increase potassium levels during treatment with this medicine.

Driving vehicles or operating machines

Telsar LN-5 Tablet may cause symptoms such as drowsiness and/or dizziness in some cases. Hence, avoid performing activities that require high mental alertness like driving vehicles or operating machines during treatment with this medicine.

Missed Dose

Do not miss the dose of Telsar LN-5 Tablet. In case you miss a dose, take it as soon as you remember. However, if it is time for the next dose, then skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Do not take more than the prescribed dose of Telsar LN-5 Tablet. Seek emergency medical treatment in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment of this medicine due to the increased risk of dizziness, fainting, and a very low blood pressure. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Dexamethasone

Diclofenac

Captopril

Insulin

Disease interactions

Congestive heart failure

Congestive heart failure (CHF) is a condition in which the heart is unable to pump blood efficiently. Telsar LN-5 Tablet should be used with caution if you have conditions such as heart failure. It may lead to oliguria (low urine output) and kidney failure. Your doctor may closely monitor the functioning of your heart and kidney while you are taking this medicine.

Kidney Disease

Telsar LN-5 Tablet is excreted via the kidney and may get accumulated in your body if your kidneys are not functioning properly. This can increase the risk of severe side effects. Hence, this medicine should be used with caution if you have kidney problems.

Hypotension

Telsar LN-5 Tablet should be used with caution as it may cause hypotension (low blood pressure). The risk is especially higher if you have low levels of sodium in your body or if you have low fluid volumes due to excessive vomiting, diarrhoea, kidney failure, etc. Hence, regularly monitor your blood pressure while you are taking this medicine.
Food interactions
Consumption of grapefruit juice is not recommended while taking this medicine due to the increased risk of adverse effects. Symptoms like dizziness, headache, swelling of hands and feet should be reported to the doctor on priority.
Lab interactions

Urinary vanillylmandelic acid

Report the use of this medicine if you have been asked to undergo this test for the presence of adrenal gland tumor. Use of this medicine is likely to give the false value that might be higher than normal.
Take Telsar LN-5 Tablet as advised by your doctor. Do not break, crush, or chew the tablet. Take this medicine at the same time every day for the ease of remembering. Avoid the discontinuation of the medicine without consulting your doctor. Exercise regularly and eat a healthy diet as it helps in maintaining your blood pressure. Avoid consuming alcohol or grapefruit juice while taking the medicine as it can increase the risk of side effects. It can make you feel dizzy. Be careful while standing up from sitting or lying down position. Avoid performing activities such as driving vehicles or operating machines if you feel dizzy or drowsy. Regularly monitor your blood pressure while you are taking this medicine.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
Telsar LN-5 Tablet is a combination of Cilnidipine and Telmisartan. Telmisartan works by blocking a receptor and preventing blood vessel constriction. Cilnidipine acts by blocking the influx of calcium (responsible for the contraction of blood vessels) and causes relaxation, thereby promoting the smooth flow of blood. Their combination is thus effective in reducing blood pressure.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Angiotensin II inhibitors with calcium channel blockers, Antihypertensive combinations

Schedule

Schedule H

Cilnidipine | C27H28N2O7 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 14 August 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/cilnidipine#section=Top

K. Sarat Chandra G. The fourth-generation Calcium channel blocker: Cilnidipine [Internet]. PubMed Central (PMC). 2017 [cited 14 August 2018]. Available from:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905258/

DailyMed - Telmisartan tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 14 August 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a907a7-fad9-a860-8639-4c6136c85734
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 13 Apr 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.